http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2446472-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f128e90355c3c49494e2e8b99cd6dec0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0649
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-0401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-07
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12
filingDate 2001-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f2fb220e7f87024a732f5552f4069b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd55ec660d49e00bae45dcac38ee07e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88a162bb800dad7716272f7344afe88c
publicationDate 2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2446472-A1
titleOfInvention Method and device for the treatment of vulnerable tissue site
abstract The present invention is directed to method and apparatus for treating vulnerable tissue site, such as aneurysms in the abdominal area or in the thoracic cavity, and expanded tissues on various organs and body surfaces su ch as the heart. The apparatus of the present invention, are containment member s (10) at least partially containing the vulnerable tissue site, thus preventi ng or minimizing the further vulnerability or growth of the site. Additionally, or alternatively, the containment members (10) can apply resistive force to the vulnerable tissues site. The force can be compressive against the exteri or surface of the tissue site. The containment members (10) of the present invention can be used alone or in combination with support members, such as stent/grafts (230), in treating a tissue site. In this embodiment, the suppo rt member is disposed within the inner lumen (203) of the vulnerable tissue sit e with the containment member disposed on the exterior surface of the lumen.</ SDOAB>
priorityDate 2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410515683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9942124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558564

Total number of triples: 38.